Dimple Kondal Selected Research

Type 2 Diabetes Mellitus (MODY)

10/2023	PM2.5 exposure, glycemic markers and incidence of type 2 diabetes in two large Indian cities.
1/2021	Factors affecting achievement of glycemic targets among type 2 diabetes patients in South Asia: Analysis of the CARRS trial.
1/2019	Rationale and protocol for estimating the economic value of a multicomponent quality improvement strategy for diabetes care in South Asia.
1/2016	Effectiveness of a Multicomponent Quality Improvement Strategy to Improve Achievement of Diabetes Care Goals: A Randomized, Controlled Trial.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Dimple Kondal Research Topics

Disease

7	Hypertension (High Blood Pressure) 01/2024 - 07/2009
5	Obesity 01/2021 - 07/2009
4	Type 2 Diabetes Mellitus (MODY) 10/2023 - 01/2016
4	Cardiovascular Diseases (Cardiovascular Disease) 11/2022 - 01/2019
2	Non-alcoholic Fatty Liver Disease 09/2023 - 01/2022
2	Fibrosis (Cirrhosis) 09/2023 - 01/2022
2	Chronic Disease (Chronic Diseases) 01/2021 - 09/2017
2	Myocardial Infarction 01/2020 - 01/2019
2	Body Weight (Weight, Body) 12/2019 - 03/2016
2	Overweight 01/2017 - 07/2009
2	Dyslipidemias (Dyslipidemia) 03/2016 - 07/2009
1	Glucose Intolerance 03/2024
1	Gallbladder Neoplasms (Gallbladder Cancer) 01/2023
1	Blindness (Hysterical Blindness) 01/2023
1	Neoplasms (Cancer) 01/2023
1	Peripheral Arterial Disease 11/2022
1	Renal Insufficiency (Renal Failure) 01/2022
1	Coronary Disease (Coronary Heart Disease) 01/2022
1	Heart Failure 01/2021
1	Hyperlipidemias (Hyperlipidemia) 01/2021
1	Insulin Resistance 01/2021
1	Obstructive Lung Diseases (Obstructive Lung Disease) 01/2021
1	Chronic Obstructive Pulmonary Disease (COPD) 01/2021
1	COVID-19 01/2021
1	Infarction (Infarctions) 01/2020
1	Stroke (Strokes) 01/2020
1	Diabetes Complications 01/2019
1	Mental Disorders (Mental Disorder) 09/2017
1	Abdominal Obesity 01/2017
1	Albuminuria 07/2015
1	Rectal Prolapse 07/2009
1	Metabolic Syndrome (Dysmetabolic Syndrome X) 07/2009
1	Hypertriglyceridemia 07/2009
1	Glaucoma 07/2007

Drug/Important Bio-Agent (IBA)

6	Glucose (Dextrose)FDA LinkGeneric 03/2024 - 07/2009
5	Blood Glucose (Blood Sugar)IBA 12/2019 - 03/2016
4	CholesterolIBA 01/2019 - 07/2009
3	Glycated Hemoglobin (Glycosylated Hemoglobin)IBA 10/2023 - 01/2016
3	LDL CholesterolIBA 01/2019 - 07/2009
2	ORALIT (ORS)IBA 01/2024 - 07/2009
2	omega-Chloroacetophenone (Mace)IBA 01/2022 - 01/2020
2	LipidsIBA 12/2019 - 07/2009
2	HDL CholesterolIBA 03/2016 - 07/2009
2	Triglycerides (Triacylglycerol)IBA 03/2016 - 07/2009
1	Aspartate Aminotransferases (Aspartate Transaminase)IBA 09/2023
1	cytoplasmic protein A (PACD)IBA 01/2023
1	ArsenicIBA 01/2023
1	Drinking WaterIBA 01/2023
1	Biomarkers (Surrogate Marker)IBA 11/2022
1	Alanine Transaminase (SGPT)IBA 01/2022
1	EnzymesIBA 01/2022
1	Oxygen (Dioxygen)IBA 01/2022
1	Insulin (Novolin)FDA Link 01/2021
1	Bronchodilator Agents (Bronchodilators)IBA 01/2021
1	Biological FactorsIBA 01/2021
1	GoldIBA 01/2021
1	Particulate MatterIBA 10/2020
1	SodiumIBA 01/2020
1	PotassiumIBA 01/2020
1	SaltsIBA 06/2019
1	Dihydrotachysterol (AT 10)IBA 01/2019
1	solanIBA 01/2019
1	CreatinineIBA 07/2015
1	Retinaldehyde (Retinal)IBA 07/2007

Therapy/Procedure

2	Therapeutics 01/2022 - 01/2021
2	Cardiac Rehabilitation 01/2020 - 01/2019
1	Glycemic Control 01/2021
1	Secondary Prevention 01/2019
1	Conservative Treatment 07/2009
1	Lasers (Laser) 07/2007